Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 known ✓ | P22748 | 4/20 | 0.35 |
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.33 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.33 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL5963065 | 0.93 | THRB (0.33) | THRB | |
| SCHEMBL6843550 | 0.93 | THRB (0.33) | THRB | |
| SCHEMBL15750747 | 0.93 | THRB (0.33) | THRB | |
| SCHEMBL6848298 | 0.93 | THRB (0.33) | THRB | |
| Silver SCHEMBL621693 | 0.93 | THRB (0.33) | THRB | |
| SCHEMBL3693055 | 0.93 | THRB (0.33) | THRB | |
| Zinc Ion SCHEMBL4581329 | 0.93 | THRB (0.33) | THRB | |
| Potassium Ion SCHEMBL1094505 | 0.93 | CA4 (0.35) | CA4FAHD1THRBMEN1LDHA | |
| SCHEMBL22598039 | 0.93 | THRB (0.33) | THRB | |
| SCHEMBL8409591 | 0.93 | THRB (0.33) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117886666-A | Preparation method of tetrafluoroethylene | 上海州达洋半导体材料有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-114560903-B | Preparation method of abiraterone derivative and cytotoxicity evaluation thereof | 绍兴市上虞区武汉理工大学高等研究院 | 2023-08-01 | — | — | CN | claimed |
| CN-113563337-B | Preparation method of camelning alkali A | 武汉理工大学 | 2023-07-04 | — | — | CN | claimed |
| CN-112852475-B | Fluorine-containing demulsifying compound and demulsifier for oil field | 天津长芦新材料研究院有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-114560903-A | Simple preparation method of abiraterone derivative and cytotoxicity evaluation of abiraterone derivative | 绍兴市上虞区武汉理工大学高等研究院 | 2022-05-31 | — | — | CN | claimed |
| CN-113563337-A | Simple preparation method of camelinine A | 武汉理工大学 | 2021-10-29 | — | — | CN | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-20260103464-A1 | CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2026-04-16 | — | — | US | disclosed |
| EP-4657572-A1 | COMPOSITION, ELECTROCHEMICAL DEVICE BINDER, ELECTRODE MIXTURE, ELECTRODE, AND SECONDARY BATTERY | Daikin Industries, Ltd. (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-20250349897-A1 | ELECTROLYTIC SOLUTION, AND ELECTROCHEMICAL DEVICE AND SECONDARY BATTERY USING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-13 | — | — | US | disclosed |
| WO-2025224604-A2 | ALKYLPHOSPHONIUM-FUNCTIONALIZED ION EXCHANGE RESINS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-10-30 | — | — | WO | disclosed |
| US-12456760-B2 | Non-aqueous electrolyte solution for sodium ion secondary battery, and sodium ion secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-10-28 | — | — | US | disclosed |
| WO-1991019708-A1 | NEW THIOPHENE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-12-26 | — | — | WO | disclosed |
| US-5021412-A | Protecting agricultural crops | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-06-04 | — | — | US | disclosed |
| EP-0396250-A1 | Pyrimidinone derivatives | ZENECA LIMITED (GB) | 1990-11-07 | — | — | EP | disclosed |
| EP-0376524-A1 | Benzopyran and related compounds | BEECHAM GROUP PLC (GB) | 1990-07-04 | — | — | EP | disclosed |
| EP-0354297-A1 | Thiadiazines, process for production thereof, and insecticidal and acaricidal agents comprising the thiadiazines | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-02-14 | — | — | EP | disclosed |
| EP-0321175-A1 | Indane derivatives | BEECHAM GROUP PLC (GB) | 1989-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12456760-B2 | Non-aqueous electrolyte solution for sodium ion secondary battery, and sodium ion secondary battery | NHERF1, NAP1L1, NAF1 | CA4 557/4885CA1 68/4885THRB 4320/4885 |
| US-20260103464-A1 | CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES | CBR3, CYCS, CBR1 | CA4 2045/4885CA1 2974/4885THRB 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.